CYTK Dividend History & Analysis | N/A Yield
CYTK has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 26.8% | 0.31% |
| ABBV | 403,129 M | 2.99% | 8.38% |
| GILD | 152,766 M | 2.54% | 6.47% |
| AMGN | 157,202 M | 2.98% | 4.68% |
| HLN | 41,279 M | 1.87% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 7,481 M | 127% | 60.7% |
| HLN | 41,279 M | 51.0% | 100% |
| AMGN | 157,202 M | 8.90% | 100% |
| ABBV | 403,129 M | 7.06% | 100% |
| GILD | 152,766 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare CYTK Dividends with its Peer-Group
2.99% Yield
2.98% Yield
2.54% Yield
1.87% Yield
CYTK Dividend History: as of November 2025
No dividends paid yet.CYTK Dividend FAQ
Cytokinetics Inc. (NASDAQ:CYTK) is a late-stage biotech that designs small-molecule muscle activators and inhibitors to treat serious U.S. diseases. Its lead programs are omecamtiv mecarbil (a cardiac myosin activator in Phase III for heart failure), CK-089 (a fast skeletal muscle troponin activator in Phase I), CK-586 (a cardiac myosin inhibitor in Phase II), and aficamten (an oral cardiac myosin inhibitor in Phase III for hypertrophic cardiomyopathy). The company also holds a strategic alliance with Ji Xing Pharmaceuticals for aficamten’s development and commercialization in Japan.
What is the Dividend Yield of CYTK?
As of November 2025, CYTK`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 60.30.Does CYTK pay a dividend?
As of November 2025 CYTK does not pay a dividend.How often does CYTK pay dividends?
Over the last 12 months, CYTK has issued dividend payments.Will CYTK pay dividends in 2025?
The next Ex-Dividend date for Cytokinetics (CYTK) is currently unknown.What is the next Ex-Dividend Date for CYTK?
The next Ex-Dividend date for Cytokinetics (CYTK) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CYTK?
CYTK's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CYTK?
CYTK's 5-Year Yield on Cost is -%. If you bought CYTK's shares at 16.86 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CYTK?
CYTK Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CYTK have a good Dividend Yield?
CYTK`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CYTK?
The Dividend Payout Ratio of CYTK is unknown.What is the Dividend Rating of CYTK?
CYTK`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-17 04:37